IGF1 and major depressive disorder: Insulin-like growth factor 1 (IGF1) is produced in the hypothalamic–pituitary–somatotropic (HPS) system and is suggested to be involved in the pathogenesis of MDD through its neuroprotective, neurogenic, and anti-inflammatory effects [16].